Adding immunotherapy to radiation didn’t help early lung cancer, and the trial stopped
In a phase 3 trial published Oct. 28, 2026, in the Journal of Clinical Oncology, adding pembrolizumab to focused radiation for early lung cancer that wasn't operated on did not delay recurrence…